Cargando…
Determinants of CD4 cell count change and time-to default from HAART; a comparison of separate and joint models
BACKGROUND: HIV has the most serious effects in Sub-Saharan African countries as compared to countries in other parts of the world. As part of these countries, Ethiopia has been affected significantly by the disease, and the burden of the disease has become worst in the Amhara Region, one of the ele...
Autores principales: | Tegegne, Awoke Seyoum, Ndlovu, Principal, Zewotir, Temesgen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5922030/ https://www.ncbi.nlm.nih.gov/pubmed/29703155 http://dx.doi.org/10.1186/s12879-018-3108-7 |
Ejemplares similares
-
Joint longitudinal data analysis in detecting determinants of CD4 cell count change and adherence to highly active antiretroviral therapy at Felege Hiwot Teaching and Specialized Hospital, North-west Ethiopia (Amhara Region)
por: Seyoum, Awoke, et al.
Publicado: (2017) -
Quasi-Poisson versus negative binomial regression models in identifying factors affecting initial CD4 cell count change due to antiretroviral therapy administered to HIV-positive adults in North–West Ethiopia (Amhara region)
por: Seyoum, Awoke, et al.
Publicado: (2016) -
Factors affecting first month adherence due to antiretroviral therapy among HIV-positive adults at Felege Hiwot Teaching and Specialized Hospital, north-western Ethiopia; a prospective study
por: Tegegne, Awoke Seyoum, et al.
Publicado: (2018) -
Predictors of non-adherence to medication and time to default from treatment on HIV infected patients under HAART: a comparison of joint and separate models
por: Abebe, Koyachew Bitew, et al.
Publicado: (2022) -
Predictors for CD4 cell count and hemoglobin level with survival time to default for HIV positive adults under ART treatment at University of Gondar Comprehensive and Specialized Hospital, Ethiopia
por: Muhie, Nurye Seid, et al.
Publicado: (2023)